Home โ€บ Stocks โ€บ LAURUSLABS

Laurus Labs Ltd share price

LAURUSLABS ยท BSE
โ‚น2,367.65โ–ผ 24.35 (-1.02%)
Open
โ‚น2,408.35
Prev close
โ‚น2,392.00
Day high
โ‚น2,442.00
Day low
โ‚น2,360.80
52-wk high
โ‚น2,433.00
52-wk low
โ‚น913.00
See Laurus Labs Ltd live on Traddx Interactive charts, deep fundamentals, peer comparison & your own watchlist โ€” one of 4,800+ NSE & BSE stocks. Free to explore, no card needed.
Open live โ†’
๐Ÿ”” Get a free alert when Laurus Labs Ltd moves Set a price alert, save LAURUSLABS to your watchlist, and unlock the full AI deep dive. Free account โ€” 10 seconds with Google, no password.
Create free account โ†’

Laurus Labs Ltd (LAURUSLABS) is a stock listed on India's exchanges (NSE & BSE). It is commonly tracked under the Pharma theme. As of the latest filings, Laurus Labs Ltd has a return on equity (ROE) of 18.30%, return on capital employed (ROCE) of 17.80%, a price-to-earnings (P/E) ratio of 95.50 and a debt-to-equity ratio of 0.43. On Traddx you can view its live price, interactive candlestick charts with 20/50/200-day moving averages and golden/death-cross detection, quarterly results, analyst price targets, peer comparison, and the smart-money signal โ€” which star investors hold it and who is buying it on today's bulk/block deals tape.

Key fundamentals

ROE
18.30%
ROCE
17.80%
P/E
95.50
Book value
โ‚น112.00
Dividend yield
0.08%
Debt / equity
0.43
Market cap
โ‚น1.28 L cr
Face value
โ‚น2.00

Source: screener.in (NSE/BSE filings) ยท Fundamentals as of 02 Nov 2026 ยท figures from the latest annual & quarterly filings. Not investment advice.

See LAURUSLABS live in the app โ†’

Laurus Labs Limited value chain โ€” customers, suppliers & competitors

Laurus Labs is a research-driven pharmaceutical and biotechnology company that manufactures Active Pharmaceutical Ingredients (APIs) and provides contract development and manufacturing services (CDMO) to global healthcare companies.

๐Ÿ›’ Customers โ€” who buys from Laurus Labs Limited

โ›“๏ธ Suppliers โ€” raw materials & inputs

  • Chemical and solvent manufacturers โ€” Basic chemical intermediates and raw materials for API synthesis
  • Key Starting Material (KSM) suppliers โ€” Advanced intermediates and KSMs

โš”๏ธ Competitors โ€” other sellers

  • Lupin Limited โ€” Competes in global API and generic formulations markets; larger scale in finished dosages.
  • Abbott India Limited โ€” Competes in domestic pharmaceutical formulations and branded generics with strong market reach.
  • Ajanta Pharma Limited โ€” Competes in specialized therapeutic segments and international generic markets.

๐Ÿ”€ Other suppliers to its customers

๐Ÿค Peers that share its suppliers

  • Suven Life Sciences โ€” Shares similar chemical raw material supply chains for contract research and manufacturing.
  • Neogen Chemicals โ€” Buys similar specialty chemicals used in complex pharma synthesis.

This value-chain map is AI-researched from public sources; company links and any figures are estimates, not official company disclosures. Not investment advice.